Discovery of a potent SCAP degrader that ameliorates HFD-induced obesity, hyperlipidemia and insulin resistance via an autophagy-independent lysosomal pathway

Author:

Zheng Zu-Guo1,Zhu Si-Tong12,Cheng Hui-Min1,Zhang Xin1,Cheng Gang3,Thu Pyone Myat1,Wang Supeng Perry4,Li Hui-Jun1,Ding Ming1,Qiang Lei1,Chen Xiao-Wei5,Zhong Qing6,Li Ping1,Xu Xiaojun12

Affiliation:

1. State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, Jiangsu, China

2. Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases, China Pharmaceutical University, Nanjing, Jiangsu, China

3. Beijing Kanglisheng Pharmaceutical Technology Development Co., Ltd, Beijing, China

4. Appleby College, Oakville, Ontario, Canada

5. State Key Laboratory of Membrane Biology, Center for Life Sciences, Institute of Molecular Medicine, Peking University, Beijing, China

6. School of Medicine, Shanghai Jiaotong University, Shanghai, China

Funder

Ministry of Science and Technology

National Natural Science Foundation of China

Natural Science Foundation of Jiangsu Province

the Ministry of Science and Technology of China

Innovative Research Group Project of the National Natural Science Foundation of China

National Science & Technology Major Project “Key New Drug Creation and Manufacturing Program“

Publisher

Informa UK Limited

Subject

Cell Biology,Molecular Biology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3